1. Home
  2. SLNO vs AVAL Comparison

SLNO vs AVAL Comparison

Compare SLNO & AVAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • AVAL
  • Stock Information
  • Founded
  • SLNO 1999
  • AVAL 1994
  • Country
  • SLNO United States
  • AVAL Colombia
  • Employees
  • SLNO N/A
  • AVAL N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • AVAL Commercial Banks
  • Sector
  • SLNO Health Care
  • AVAL Finance
  • Exchange
  • SLNO Nasdaq
  • AVAL Nasdaq
  • Market Cap
  • SLNO 3.8B
  • AVAL 3.4B
  • IPO Year
  • SLNO 2014
  • AVAL N/A
  • Fundamental
  • Price
  • SLNO $79.98
  • AVAL $2.86
  • Analyst Decision
  • SLNO Strong Buy
  • AVAL
  • Analyst Count
  • SLNO 9
  • AVAL 0
  • Target Price
  • SLNO $103.33
  • AVAL N/A
  • AVG Volume (30 Days)
  • SLNO 662.7K
  • AVAL 120.6K
  • Earning Date
  • SLNO 08-06-2025
  • AVAL 08-15-2025
  • Dividend Yield
  • SLNO N/A
  • AVAL 3.80%
  • EPS Growth
  • SLNO N/A
  • AVAL 195.30
  • EPS
  • SLNO N/A
  • AVAL 0.01
  • Revenue
  • SLNO N/A
  • AVAL $2,951,771,633.00
  • Revenue This Year
  • SLNO N/A
  • AVAL $46.54
  • Revenue Next Year
  • SLNO N/A
  • AVAL $8.90
  • P/E Ratio
  • SLNO N/A
  • AVAL $11.33
  • Revenue Growth
  • SLNO N/A
  • AVAL 14.20
  • 52 Week Low
  • SLNO $36.93
  • AVAL $1.94
  • 52 Week High
  • SLNO $81.54
  • AVAL $3.32
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 60.77
  • AVAL 53.01
  • Support Level
  • SLNO $76.14
  • AVAL $2.72
  • Resistance Level
  • SLNO $81.54
  • AVAL $3.00
  • Average True Range (ATR)
  • SLNO 2.49
  • AVAL 0.12
  • MACD
  • SLNO 0.00
  • AVAL -0.01
  • Stochastic Oscillator
  • SLNO 81.81
  • AVAL 50.00

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About AVAL Grupo Aval Acciones y Valores S.A. ADR (Each representing 20 preferred shares)

Grupo Aval Acciones y Valores SA is a Colombian financial services company. Its segments include: Banking Services segment comprises Banking Services, fund management and trust businesses, storage companies and entities that manage low-value payment systems. Merchant Banking segment comprises Financial Sector (trust and brokerage), Gas and Energy Sector (includes natural gas and energy transportation and distribution businesses), Infrastructure Sector (includes road infrastructure projects, construction services, and operation and maintenance), Hotel Sector (includes hospitality services), Agribusiness Sector (includes palm oil, rubber and rice businesses). Pension and Severance Fund Management" segment comprise administrator of pension and severance funds; and Holding segment.

Share on Social Networks: